Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: A new approach to cancer immunotherapy

Cancer Immunology, Immunotherapy

Volumn 53, Issue 1, 2004, Pages 53-61

  Sato, Takami ^a   Terai, Mizue ^a   Yasuda, Rie ^b   Watanabe, Ryuko ^b   Berd, David ^a   Mastrangelo, Michael J ^a   Hasumi, Kenichiro ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Electro Chem and Cancer Res Inst   (Japan)

Author keywords

Activated T cells; CD40 ligand; Dendritic cells; Interleukin 12; Macrophage inflammatory protein 3

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PHYTOHEMAGGLUTININ;

ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; COCULTURE; CYTOKINE PRODUCTION; DENDRITIC CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANTIGENS, CD; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; CALCIUM; CD40 LIGAND; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; COCULTURE TECHNIQUES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; UP-REGULATION;

EID: 0742269448     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0419-2     Document Type: Article

References (36)

1. Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR (1993) CD40 ligand is a T cell growth factor. Eur J Immunol 23:2326
2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245
3. Bianchi R, Grohmann U, Vacca C, Belladonna ML, Fioretti MC, Puccetti P (1999) Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation. J Immunol 163:2517
4. Bjorck P, Banchereau J, Flores-Romo L (1997) CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 9:365
5. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-alpha cooperation in the generation of dendritic Langerhans cells. Nature 360:258
6. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1236
7. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747
8. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A (1997) Inflammatory stimuli induce accumulation of MHC class II complexs on dendritic cells. Nature 388:782
9. Dieu MC, Vanbervleit B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373
10. Egner W, Hart DN (1995) The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: Possible heterogeneity in bone marrow dendritic cell populations. Immunol 85:611
11. Enk AH, Jonuleit H, Saloga J, Knop J (1997) Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73:309
12. Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell FJ (1994) Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 152:4262
13. Gao JX, Madrenas J, Zeng W, Cameron, MJ, Zhang Z, Wang JJ, Zhong R, Grant D (1999) CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunol 98:159
14. Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H (2000) CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes. Cancer Res 60:2209
15. Kato T, Yamane H, Nariuchi H (1997) Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages. Cell Immunol 181:59
16. Kelsall BL, Stuber E, Neurath M, Strober W (1996) Interleukin-12 production by dendritic cells: the role of CD40-CD40L interactions in Th1 T-cell responses. Ann NY Acad Sci 795:116
17. Kern JA, Reed JC, Daniele RP, Nowell PC (1986) The role of accessory cells in mitogen-stimulated human T cell gene expression. J Immunol 137:764
18. Mackey MF, Gunn JR, Maliszewsky C, Kikutani H, Noelle RJ, Barth RJ Jr (1998) Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161:2094
19. McDyer JF, Goletz TJ, Thomas E, June CH, Seder RA (1998) CD40 ligand/ CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12-and/or CD28-dependent manner. J Immunol 160:1701
20. McLellan AD, Sorg RV, Williams LA, Hart DNJ (1996) Human dendritic cells activate T lymphocytes via a CD40:CD40 ligand-dependent pathway. Eur J Immunol 26:1204
21. Nusslein HG, Frosch K-H, Woith W, Lane P, Kalden JR, Manger B (1996) Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur J Immunol 26:846
22. Perles B, Flanagan MT, Auger J, Crumpton MJ (1997) Mechanism of lymphocyte activation: the binding of phytohemagglutinin to the lymphocyte surface. Eur J Immunol 7:613
23. Piere P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 288:787
24. Reid CD, Stackpoole A, Meager A, Tikerpae J (1992) Interaction of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 149:2681
25. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM (1995) Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181:2237
26. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83
27. Romani N, Rieder D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwiesser B, Schuler G (1996) Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Method 196:137
28. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J Exp Med 179:1109
29. Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389
30. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480
31. Snijiders A, Kalinski P, Hilkens CM, Kapsenberg ML (1998) High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 10:1593
32. Sozzani S, Allavena PD, Amico G, Luini W, Bianchi G, Kataura M, Imai T, Yoshie O, Bonecchi R, Mantovani A (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161:1083
33. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271
34. 2+ and membrane potential in lymphocytes. Nature 295:68
35. Wojtowicz-Praga S (1997) Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20:165
36. Yanagihara S, Komura E, Nagafune J, Watatai H, Yamaguchi Y (1998) ERI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 161: 3096